OTC Drug Review’s Constitutionality Questioned By CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency
You may also be interested in...
Labeling Based On Consumer Comprehension Data Stressed By McClellan
Empirical data on consumer comprehension of food and drug labeling would play a prominent role in FDA rulemaking if the Senate confirms White House economic advisor Mark McClellan, MD/PhD, as the agency's new commissioner
Supplement Promos To Health Professionals Merit More Flexibility – AHPA
Dietary supplement promotional speech targeted to health care practitioners should be allowed to contain substantiated disease treatment claims, the American Herbal Products Association maintains
Supplement Claims Rules v. Drugs, Foods: FDA Opens Free Speech Debate
FDA invites public comments on the constitutionality of its approach to regulating claims for dietary supplements compared with Rx drugs and foods in a notice appearing in the May 16 Federal Register